How many employees does MaxCyte have this year?
MaxCyte has 65 undefined employees this year.
MaxCyte Employees 2024
MaxCyte Employees
65
Ticker
MXCT
ISIN
US57777K1060
WKN
A2AGVE
In 2024, MaxCyte employed 65 people, a 0% change from the 65 number of employees in the previous year.
MaxCyte Aktienanalyse
What does MaxCyte do?
MaxCyte Inc is a US biotechnology company specializing in the development of platform-based technologies for the next generation of gene and cell therapies. They offer integrated platform technology for drug manufacturing, research, and development. Their proprietary platform technology, Flow ElectroporationTM, allows for efficient transduction of a variety of cells, making it a valuable tool for the production of CAR-T cell therapies. They also offer services for lentiviral production and customized gene therapy production. MaxCyte has secured $50 million in funding for expansion and has formed important partnerships in the industry. They are a leading player in the development of innovative technologies for gene and cell therapy products. MaxCyte ist eines der beliebtesten Unternehmen auf Eulerpool.com.Employees Details
Examining MaxCyte's Employee Base
MaxCyte's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding MaxCyte's operational capacity and future potential.
Year-to-Year Comparison
Assessing MaxCyte's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Impact on Investments
MaxCyte's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Interpreting Employee Trends
Fluctuations in MaxCyte’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Frequently Asked Questions about MaxCyte stock
How many employees did MaxCyte have compared to the previous year?
Compared to the previous year, MaxCyte had 0% more employees.
What impact did the number of employees have on the company MaxCyte?
The number of employees has a direct impact on the efficiency and productivity of MaxCyte. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
What impact did the number of employees have on investors of MaxCyte?
The number of employees can also have an impact on investors of MaxCyte, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
How does an increase in equity capital of MaxCyte affect the company?
An increase in equity of MaxCyte can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
How does a reduction in MaxCyte's equity affect the company?
A reduction in equity of MaxCyte can impair its financial stability and decrease its ability to fulfill future investments and obligations.
What are some factors that influence the equity of MaxCyte?
Some factors that can influence the equity of MaxCyte include, among others, revenue development, profit and loss statement, dividend payments, and investments.
Why is the equity of MaxCyte so important for investors?
The equity of MaxCyte is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
How does the number of employees at MaxCyte influence the company?
The number of employees at MaxCyte can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
How has the number of employees at MaxCyte evolved in recent years?
In recent years, the number of employees at MaxCyte has changed by 0.
How many employees does MaxCyte currently have?
MaxCyte currently has 65 undefined employees.
Why is the number of employees important for investors of MaxCyte?
The number of employees is important for investors of MaxCyte as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
What strategic measures can MaxCyte take to change the number of employees?
To change the number of employees, MaxCyte can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
How much dividend does MaxCyte pay?
Over the past 12 months, MaxCyte paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MaxCyte is expected to pay a dividend of 0 USD.
What is the dividend yield of MaxCyte?
The current dividend yield of MaxCyte is .
When does MaxCyte pay dividends?
MaxCyte pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MaxCyte?
MaxCyte paid dividends every year for the past 0 years.
What is the dividend of MaxCyte?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is MaxCyte located?
MaxCyte is assigned to the 'Health' sector.
Wann musste ich die Aktien von MaxCyte kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MaxCyte from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.
When did MaxCyte pay the last dividend?
The last dividend was paid out on 9/29/2024.
What was the dividend of MaxCyte in the year 2023?
In the year 2023, MaxCyte distributed 0 USD as dividends.
In which currency does MaxCyte pay out the dividend?
The dividends of MaxCyte are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von MaxCyte
Our stock analysis for MaxCyte Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MaxCyte Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.